Dachaigh › Liomfoma Neo-Hodgkin
Sgrùdaidhean clionaigeach Liomfoma Neo-Hodgkin a’ fastadh anns na SA
Tha 127 sgrùdaidhean airson Liomfoma Neo-Hodgkin a’ fastadh phàirtichean aig làraichean air feadh nan Stàitean Aonaichte.
Bailtean leis na sgrùdaidhean as motha
- Houston, TX31 sgrùdaidhean
- New York City, NY31 sgrùdaidhean
- Boston, MA26 sgrùdaidhean
- Nashville, TN21 sgrùdaidhean
- Philadelphia, PA20 sgrùdaidhean
- Baldwin Park, CA19 sgrùdaidhean
- Atlanta, GA18 sgrùdaidhean
- Chicago, IL18 sgrùdaidhean
- Columbus, OH18 sgrùdaidhean
- Milwaukee, WI18 sgrùdaidhean
- Washington, DC18 sgrùdaidhean
- Dallas, TX17 sgrùdaidhean
- Seattle, WA16 sgrùdaidhean
- Durham, NC16 sgrùdaidhean
- Portland, OR15 sgrùdaidhean
- Rochester, MN14 sgrùdaidhean
- Miami, FL14 sgrùdaidhean
- Omaha, NE14 sgrùdaidhean
- Denver, CO14 sgrùdaidhean
- Cleveland, OH13 sgrùdaidhean
- Salt Lake City, UT13 sgrùdaidhean
- Mountain View, CA12 sgrùdaidhean
- St. Louis, MO11 sgrùdadh
- Aurora, CO11 sgrùdadh
- Los Angeles, CA9 sgrùdaidhean
- Tampa, FL9 sgrùdaidhean
- Jacksonville, FL9 sgrùdaidhean
- Cincinnati, OH9 sgrùdaidhean
- San Francisco, CA9 sgrùdaidhean
- Pittsburgh, PA8 sgrùdaidhean
- San Diego, CA8 sgrùdaidhean
- Ann Arbor, MI8 sgrùdaidhean
- Cedar Rapids, IA8 sgrùdaidhean
- Baltimore, MD8 sgrùdaidhean
- Buffalo, NY7 sgrùdaidhean
- Clifton, NJ7 sgrùdaidhean
- Kansas City, MO7 sgrùdaidhean
- Birmingham, AL7 sgrùdaidhean
- Edison, NJ7 sgrùdaidhean
- Queens, NY7 sgrùdaidhean
Le stàit
- Alabama7 sgrùdaidhean
- Arizona14 sgrùdaidhean
- Arkansas5 sgrùdaidhean
- California42 sgrùdaidhean
- Colorado20 sgrùdaidhean
- Connecticut8 sgrùdaidhean
- Delaware4 sgrùdaidhean
- Florida32 sgrùdaidhean
- Georgia21 sgrùdaidhean
- Hawaii3 sgrùdaidhean
- Idaho3 sgrùdaidhean
- Illinois20 sgrùdaidhean
- Indiana10 sgrùdaidhean
- Iowa10 sgrùdaidhean
- Kansas9 sgrùdaidhean
- Kentucky5 sgrùdaidhean
- Louisiana6 sgrùdaidhean
- Maine4 sgrùdaidhean
- Maryland21 sgrùdaidhean
- Massachusetts28 sgrùdaidhean
- Michigan13 sgrùdaidhean
- Minnesota19 sgrùdaidhean
- Mississippi3 sgrùdaidhean
- Missouri10 sgrùdaidhean
- Montana3 sgrùdaidhean
- Nebraska15 sgrùdaidhean
- New Jersey13 sgrùdaidhean
- New Mexico4 sgrùdaidhean
- New York40 sgrùdaidhean
- North Carolina24 sgrùdaidhean
- North Dakota3 sgrùdaidhean
- Ohio34 sgrùdaidhean
- Oklahoma3 sgrùdaidhean
- Oregon15 sgrùdaidhean
- Pennsylvania26 sgrùdaidhean
- Rhode Island5 sgrùdaidhean
- Sgìre Cholumbia4 sgrùdaidhean
- South Carolina5 sgrùdaidhean
- South Dakota3 sgrùdaidhean
- Tennessee24 sgrùdaidhean
- Texas48 sgrùdaidhean
- Utah14 sgrùdaidhean
- Virginia13 sgrùdaidhean
- Washington20 sgrùdaidhean
- West Virginia3 sgrùdaidhean
- Wisconsin20 sgrùdaidhean
Sgrùdaidhean air an ùrachadh o chionn ghoirid
Teacsa sgrùdaidh oifigeil (Beurla)
Activated T-Cells Expressing 2nd or 3rd Generation CD19-Specific CAR, Advanced B-Cell NHL, ALL, and CLL (SAGAN)
A’ fastadhÌre 1
Suas gu aois 75 · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT01853631Constitutive IL7R (C7R) Modified Banked Allogeneic CD30.CAR EBVSTS for CD30-Positive Lymphomas
A’ fastadhÌre 1
Aoisean 12 gu 75 · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT06176690CD30 CAR T Cells, Relapsed CD30 Expressing Lymphoma (RELY-30)
A’ fastadhÌre 1
Aoisean 12 gu 75 · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT02917083Intrathecal Cytarabine and Hydrocortisone for the Early Treatment of ICANS in Patients Undergoing CAR T Therapy for Non Hodgkin Lymphoma
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT07763210A Clinical Trial to Evaluate Efficacy, Safety, and Pharmacokinetics of Gamunex in Participants With Secondary Antibody Deficiency Associated With Chronic Lymphocytic Leukemia, Multiple Myeloma, or Non-Hodgkin Lymphoma
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 1 Dàmh 2026 · NCT07582432T-Cell Therapy (EB103) in Adults With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (NHL)
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 1 Dàmh 2026 · NCT06343311Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
A’ fastadhSgrùdadh amharc
Aoisean 0 gu 38 · Gach gnè · Air ùrachadh 1 Dàmh 2026 · NCT06131801CD19/CD22 Bicistronic Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory B Cell Malignancies
A’ fastadhÌre 1/2
Aoisean 3 gu 39 · Gach gnè · Air ùrachadh 30 Sult 2026 · NCT05442515A Study to Evaluate Efficacy, Safety, and PK of XEMBIFY®+Standard Medical Treatment (SMT) Compared to Placebo+SMT to Prevent Infections in Participants With HGG and Recurrent or Severe Infections Associated With B-cell Chronic Lymphocytic Leukemia, Multiple Myeloma, and Non-Hodgkin Lymphoma
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 30 Sult 2026 · NCT05645107NT-I7 (Efineptakin Alfa), a Long-acting Human IL-7, Post-Axicabtagene Ciloleucel or Post-Lisocabtagene Maraleucel in Subjects With Relapsed/Refractory Large B-cell Lymphoma
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 29 Sult 2026 · NCT07052305A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 28 Sult 2026 · NCT05006716Biospecimen Procurement for Center for Immuno-Oncology Immunotherapy Protocols
A’ fastadhSgrùdadh amharc
Aoisean 18 gu 120 · Gach gnè · Air ùrachadh 28 Sult 2026 · NCT02682667Tissue Collection for Studies of Lymph Cancer
A’ fastadhSgrùdadh amharc
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 28 Sult 2026 · NCT01676805Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Revlimid (ViPOR) in Relapsed/Refractory B-cell Lymphoma
A’ fastadhÌre 1/2
Aoisean 18 gu 120 · Gach gnè · Air ùrachadh 28 Sult 2026 · NCT03223610A Clinical Study of MK-1045 in People With Non-Hodgkin Lymphoma (MK-1045-008)
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT07519772Daratumumab for Relapsed/Refractory Primary Effusion Lymphoma, Plasmablastic Lymphoma, and Multicentric Castleman Disease
A’ fastadhÌre 2
Aoisean 18 gu 120 · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT05907759Epco, Zanu, Ritux for R/R FL or MZL
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT06563596Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies
A’ fastadhÌre 1 tràth
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 24 Sult 2026 · NCT06398457Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 24 Sult 2026 · NCT04728893A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 22 Sult 2026 · NCT07226843A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 22 Sult 2026 · NCT07101328TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
A’ fastadhÌre 2
Aoisean 12 agus nas sine · Gach gnè · Air ùrachadh 22 Sult 2026 · NCT02693535Collection of Human Samples to Study Hairy Cell and Other Leukemias, and to Develop Recombinant Immunotoxins for Cancer Treatment
A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 22 Sult 2026 · NCT01087333Acalabrutinib With DA-EPOCH-R or R-CHOP for People With Untreated Diffuse Large B-cell Lymphoma
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 16 Sult 2026 · NCT04002947Safety and Preliminary Efficacy of MT-601 in Patients With Relapsed/Refractory Lymphoma
A’ fastadhÌre 1
Aoisean 18 gu 100 · Gach gnè · Air ùrachadh 15 Sult 2026 · NCT05798897Bho ClinicalTrials.gov, dàta air a thogail 5 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.